References
- The Ofloxacin Study Group. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group. Ophthalmology. 1997;104(11):1902–1909.
- O‘Brien TP, Maguire MG, Fink NE, Alfonso E, McDonnell P. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the bacterial keratitis study research group. Arch Ophthalmol(Chicago, Ill: 1960). 1995; 113(10):1257–1265.
- Constantinou M, Daniell M, Snibson GR, Vu HT, Taylor HR. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial. Ophthalmology. 2007;114(9):1622–1629. doi:10.1016/j.ophtha.2006.12.011.
- Prajna NV, John RK, Nirmalan PK, Lalitha P, Srinivasan M. A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis. Br J Ophthalmol. 2003;87:1235–1237.
- Rahman MR, Johnson GJ, Husain R, Howlader SA, Minassian DC. Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh. Br J Ophthalmol. 1998;82:919–925.
- Lim N, Goh D, Bunce C, et al. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. Am J Ophthalmol. 2008;145(1):130–135. doi:10.1016/j.ajo.2007.08.040.
- Prajna NV, Mascarenhas J, Krishnan T, et al. Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Arch Ophthalmol(Chicago, Ill: 1960). 2010;128(6):672–678. doi:10.1001/archophthalmol.2010.102.
- Katz J, Khatry SK, Thapa MD, et al. A randomised trial of povidone-iodine to reduce visual impairment from corneal ulcers in rural Nepal. Br J Ophthalmol. 2004;88(12):1487–1492. doi:10.1136/bjo.2004.044412.
- Srinivasan M, Mascarenhas J, Rajaraman R, et al. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol (Chicago, Ill: 1960). 2012;130(2):143–150. doi:10.1001/archophthalmol.2011.315.
- Prajna NV, Krishnan T, Mascarenhas J, et al. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol. 2013;131(4):422–429.
- McAlinden C, Khadka J, Pesudovs K. Precision (repeatability and reproducibility) studies and sample-size calculation. J Cataract Refract Surg. 2015;41(12):2598–2604. doi:10.1016/j.jcrs.2015.06.029.
- Oatts JT, Keenan JD, Mannis T, Lietman TM, Rose-Nussbaumer J. Multimodal assessment of corneal thinning using optical coherence tomography, Scheimpflug imaging, pachymetry, and slit-lamp examination. Cornea. 2017;36(4):425–430. doi:10.1097/ICO.0000000000001151.
- Otchere H, Sorbara L. Repeatability of topographic corneal thickness in keratoconus comparing Visante OCT and Oculus Pentacam HR((R)) topographer. Cont Lens Anterior Eye. 2017;40(4):217–223. doi:10.1016/j.clae.2017.05.002.
- Wang Q, Hua Y, Savini G, et al. Corneal power measurement obtained by fourier-domain optical coherence tomography: repeatability, reproducibility, and comparison with Scheimpflug and automated keratometry measurements. Cornea. 2015;34(10):1266–1271. doi:10.1097/ICO.0000000000000564.
- Wang Q, Ding X, Savini G, et al. Anterior chamber depth measurements using Scheimpflug imaging and optical coherence tomography: repeatability, reproducibility, and agreement. J Cataract Refract Surg. 2015;41(1):178–185. doi:10.1016/j.jcrs.2014.04.038.